Haleon PLC Sponsored ADR $HLN Position Raised by Jones Financial Companies Lllp

Jones Financial Companies Lllp grew its position in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 16.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 355,851 shares of the company’s stock after acquiring an additional 49,560 shares during the quarter. Jones Financial Companies Lllp’s holdings in Haleon were worth $3,139,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of HLN. Bank of America Corp DE lifted its position in Haleon by 116.7% in the 2nd quarter. Bank of America Corp DE now owns 12,384,135 shares of the company’s stock valued at $128,423,000 after purchasing an additional 6,669,923 shares during the last quarter. Acadian Asset Management LLC raised its holdings in shares of Haleon by 3,031.5% during the second quarter. Acadian Asset Management LLC now owns 5,384,661 shares of the company’s stock valued at $55,813,000 after buying an additional 5,212,711 shares during the last quarter. BNP Paribas Financial Markets raised its holdings in shares of Haleon by 3,548.4% during the second quarter. BNP Paribas Financial Markets now owns 1,684,968 shares of the company’s stock valued at $17,473,000 after buying an additional 1,638,784 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of Haleon by 15.5% during the second quarter. JPMorgan Chase & Co. now owns 8,776,686 shares of the company’s stock worth $91,014,000 after buying an additional 1,174,813 shares during the period. Finally, Rockefeller Capital Management L.P. grew its holdings in Haleon by 1,182.6% in the 2nd quarter. Rockefeller Capital Management L.P. now owns 1,197,068 shares of the company’s stock worth $12,414,000 after buying an additional 1,103,738 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on HLN shares. Jefferies Financial Group reaffirmed a “buy” rating on shares of Haleon in a research note on Tuesday, January 20th. Morgan Stanley reaffirmed an “overweight” rating on shares of Haleon in a report on Monday, December 15th. Deutsche Bank Aktiengesellschaft cut shares of Haleon from a “hold” rating to a “sell” rating in a research note on Monday, January 12th. Weiss Ratings restated a “hold (c)” rating on shares of Haleon in a research report on Thursday, January 22nd. Finally, HSBC upgraded shares of Haleon from a “hold” rating to a “strong-buy” rating in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Haleon presently has a consensus rating of “Moderate Buy” and an average price target of $12.33.

Haleon Price Performance

Shares of NYSE HLN opened at $10.98 on Friday. Haleon PLC Sponsored ADR has a twelve month low of $8.71 and a twelve month high of $11.42. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. The firm has a 50-day moving average of $10.03 and a two-hundred day moving average of $9.66. The company has a market capitalization of $48.90 billion, a price-to-earnings ratio of 28.15 and a beta of 0.19.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.